Friday, April 07, 2006

ADHD Patch Approved by FDA

From the CEC Smart Brief:

The Food and Drug Administration Thursday approved the once-a-day Daytrana skin patch, which delivers a generic version of Ritalin, for treatment of children ages 6 to 12 with ADHD. Experts say the patch will particularly help children who have trouble taking pills. Reuters (4/7)

No comments:

Promethean Planet


The following is the opinion of the writer and is not intended to malign any religion, ethnic group, club, organization, company, or individual. Any view or opinion represented in the blog comments are personal and is accredited to the respective commentor / visitor to this blog. This blogger reserves the right to moderate comment suitability in support of respecting racial, religious and political sensitivities, and in order to protect the rights of each commentor where available.